Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 2 search results for "Selegiline" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Side Effects of Parkinson’s Disease Treatment
... Catechol-O-methyltransferase (COMT) inhibitors such as entacapone (Comtan), opicapone (Ongentys), and tolcapone (Tasmar; rarely used because it can harm the liver) Dopamine agonists such as apomorphine (Apokyn), pramipexole dihydrochloride, rotigotine (Neupro), and ropinirole Monoamine oxidase inhibitors such as rasagiline (Azilect), safinamide (Xadago), and selegiline ...
Side Effects of Parkinson’s Disease Treatment
... Catechol-O-methyltransferase (COMT) inhibitors such as entacapone (Comtan), opicapone (Ongentys), and tolcapone (Tasmar; rarely used because it can harm the liver) Dopamine agonists such as apomorphine (Apokyn), pramipexole dihydrochloride, rotigotine (Neupro), and ropinirole Monoamine oxidase inhibitors such as rasagiline (Azilect), safinamide (Xadago), and selegiline ...
How To Treat Parkinson’s Disease and Parkinsonism
... This, in turn, improves motor symptoms of Parkinson’s disease.MAO B inhibitors include: Rasagiline (Azilect) Safinamide (Xadago) Selegiline (Eldepryl and Zelapar) The most common side effects of MAO B inhibitors include: Mild nausea Lightheadedness Constipation Confusion Hallucinations Symptom Management MedicationsIn addition to medications that target ...
How To Treat Parkinson’s Disease and Parkinsonism
... This, in turn, improves motor symptoms of Parkinson’s disease.MAO B inhibitors include: Rasagiline (Azilect) Safinamide (Xadago) Selegiline (Eldepryl and Zelapar) The most common side effects of MAO B inhibitors include: Mild nausea Lightheadedness Constipation Confusion Hallucinations Symptom Management MedicationsIn addition to medications that target ...